title: Platelets and inflammatory markers in patients with gastric cancer.
abstract: The aim of the study was to assess the contribution of platelets and inflammatory markers in gastric cancer. We studied 50 patients. Taking into consideration the advancement of gastric cancer, patients were divided into 3 groups. Group (E)--13 patients with early gastric cancer, group (A)--18 patients with regionally advanced cancer, and group (M)--19 patients with metastatic cancer. The determinations were performed twice prior to surgery and after surgery. In patients with gastric cancer, there is an increase in IL-6 and IL-23 compared with the healthy group. The highest values of IL-6 were obtained in early cancer (more than 8-fold increase), which seems to confirm the presence of acute inflammation. The lowest value of both of these cytokines was obtained in patients with metastatic cancer. In all patients, regardless of tumor stage, there was an increase in the concentration of CRP. An increase of PLT, higher proportion of the percentage of large platelets (LPLT), and increased mean platelet volume (MPV) were observed in the process of disease development. A positive correlation between MPV and LPLT and the accompanying decrease in the concentration of proinflammatory cytokines indicates the presence of an existing relationship between the platelet morphological parameters and the inflammation process in the development of gastric cancer.
authors.affiliation: Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, J. Waszyngton 15a, 15-269 Bialystok, Poland. matowic@umb.edu.pl
authors.forename: Joanna
authors.initials: J
authors.lastname: Matowicka-Karna
authors.forename: Zbigniew
authors.initials: Z
authors.lastname: Kamocki
authors.forename: Beata
authors.initials: B
authors.lastname: Polińska
authors.forename: Joanna
authors.initials: J
authors.lastname: Osada
authors.forename: Halina
authors.initials: H
authors.lastname: Kemona
mesh_terms: D000328:Adult; D000368:Aged; D001792:Blood Platelets / Q000276:immunology*; D002097:C-Reactive Protein / Q000378:metabolism; D002452:Cell Count; D002471:Cell Transformation, Neoplastic / Q000276:immunology; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D018836:Inflammation Mediators / Q000276:immunology*; D053759:Interleukin-23 / Q000276:immunology; D015850:Interleukin-6 / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D013274:Stomach Neoplasms / Q000276:immunology*
chemical_list: D018836:Inflammation Mediators; D053759:Interleukin-23; D015850:Interleukin-6; D002097:C-Reactive Protein
references.citation: BMC Cancer. 2009 May 20;9:155
references.pmid: 19457231
references.citation: Gastric Cancer. 2002;5(3):137-41
references.pmid: 12378339
references.citation: Gastric Cancer. 2005;8(2):124-31
references.pmid: 15864720
references.citation: Gastric Cancer. 2005;8(2):86-94
references.pmid: 15864715
references.citation: Neoplasma. 2010;57(2):145-50
references.pmid: 20099978
references.citation: Aliment Pharmacol Ther. 1999 Mar;13 Suppl 1:13-8
references.pmid: 10209682
references.citation: J Inflamm (Lond). 2004 Sep 30;1(1):3
references.pmid: 15813980
references.citation: Blood Rev. 2009 Jul;23(4):177-89
references.pmid: 19450911
references.citation: Int J Cancer. 2007 Dec 1;121(11):2373-80
references.pmid: 17893866
references.citation: J Oncol. 2010;2010:468725
references.pmid: 20369064
references.citation: Platelets. 2002 Aug-Sep;13(5-6):301-6
references.pmid: 12189016
references.citation: Lancet. 2009 Aug 8;374(9688):477-90
references.pmid: 19625077
references.citation: Scand J Gastroenterol. 2010 Aug;45(7-8):1005-6
references.pmid: 20377467
references.citation: Chang Gung Med J. 2009 Sep-Oct;32(5):471-82
references.pmid: 19840504
references.citation: Methods Mol Biol. 2009;472:467-77
references.pmid: 19107449
references.citation: Semin Thromb Hemost. 2007 Mar;33(2):119-22
references.pmid: 17340458
references.citation: Endoscopy. 1998 Sep;30(7):643-9
references.pmid: 9826145
references.citation: Oncoimmunology. 2012 Oct 1;1(7):1146-1155
references.pmid: 23170261
references.citation: Expert Opin Ther Targets. 2010 Jul;14(7):759-74
references.pmid: 20536413
references.citation: Lancet Oncol. 2002 Jul;3(7):425-30
references.pmid: 12142172
references.citation: Lancet. 2000 Apr 29;355(9214):1531-9
references.pmid: 10801186
references.citation: Gastric Cancer. 2009;12(2):95-100
references.pmid: 19562463
references.citation: Br J Haematol. 2001 Jul;114(1):126-33
references.pmid: 11472357
references.citation: Oncol Rep. 2013 Jan;29(1):34-8
references.pmid: 23117246
references.citation: Am J Gastroenterol. 1996 Jul;91(7):1417-22
references.pmid: 8678006